Transaction in Own Shares
December 08 2008 - 8:42AM
UK Regulatory
Transaction in Own Shares
Novo Nordisk A/S - Share repurchase programme
On 15 August 2008 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an
amount of up to DKK 1.7 billion in the period from 15 August 2008 to
19 December 2008.
Since the announcement as of 1 December 2008, the following
transactions have been made under the programme:
Number of Average Transaction
shares purchase price value, DKK
Accumulated, last
announcement 4,326,500 1,227,666,254
1 December 2008 97,500 294.7800 28,741,050
2 December 2008 90,000 290.2800 26,125,200
3 December 2008 80,000 298.1400 23,851,200
4 December 2008 110,000 299.5400 32,949,400
5 December 2008 105,000 297.4600 31,233,300
Accumulated under
the programme 4,809,000 1,370,566,404
With the transactions stated above, Novo Nordisk owns a total of
25,775,785 treasury shares, corresponding to 4.1% of the share
capital. The total amount of shares in the company is 634,000,000
including treasury shares.
Novo Nordisk is a healthcare company and a world leader in diabetes
care. In addition, Novo Nordisk has a leading position within areas
such as haemostasis management, growth hormone therapy and hormone
replacement therapy. Novo Nordisk manufactures and markets
pharmaceutical products and services that make a significant
difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs approximately 26,550
employees in 80 countries, and markets its products in 179 countries.
Novo Nordisk's B shares are listed on the stock exchanges in
Copenhagen and London. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.
Further information:
Media: Investors:
Elin K Hansen Mads Veggerby Lausten
Tel: (+45) 4442 3450 Tel: (+45) 4443 7919
ekh@novonordisk.com mlau@novonordisk.com
Hans Rommer
In North America: Tel: (+45) 4442 4765
Sean Clements hrmm@novonordisk.com
Tel: (+1) 609 514 8316
secl@novonordisk.com Kasper Roseeuw Poulsen
Tel: (+45) 4442 4471
krop@novonordisk.com
Company Announcement no 80 / 2008
http://hugin.info/2013/R/1275838/284036.pdf
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
Novo-N.Dkk1'b' (LSE:NVOB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Novo-N.Dkk1'b' (LSE:NVOB)
Historical Stock Chart
From Aug 2023 to Aug 2024